hypothyroidism 发表于 2025-3-21 18:36:52

        SCIE(SCI)期刊CLINICAL NEUROPHARMACOLOGY(20 21 REV HIST)影响因子<br>        http://impactfactor.cn/2024/if/?ISSN=0362-5664<br><br>        SCIE(SCI)期刊CLINICAL NEUROPHARMACOLOGY(CLIN NEUROPHARMACOL)影响因子@(药理学与药学)学科排名<br>        http://impactfactor.cn/2024/ifr/?ISSN=0362A5664<br><br>        SCIE(SCI)期刊CLINICAL NEUROPHARMACOLOGY(20 21 REV HIST)总引论文<br>        http://impactfactor.cn/2024/at/?ISSN=0362-5664<br><br>        SCIE(SCI)期刊CLINICAL NEUROPHARMACOLOGY(CLIN NEUROPHARMACOL)总引论文@(药理学与药学)学科排名<br>        http://impactfactor.cn/2024/atr/?ISSN=0362A5664<br><br>        SCIE(SCI)期刊CLINICAL NEUROPHARMACOLOGY(20 21 REV HIST)影响因子<br>        http://impactfactor.cn/2024/tc/?ISSN=0362-5664<br><br>        SCIE(SCI)期刊CLINICAL NEUROPHARMACOLOGY(CLIN NEUROPHARMACOL)总引频次@(药理学与药学)学科排名<br>        http://impactfactor.cn/2024/tcr/?ISSN=0362A5664<br><br>        SCIE(SCI)期刊CLINICAL NEUROPHARMACOLOGY(20 21 REV HIST)即时影响因子<br>        http://impactfactor.cn/2024/ii/?ISSN=0362-5664<br><br>        SCIE(SCI)期刊CLINICAL NEUROPHARMACOLOGY(CLIN NEUROPHARMACOL)即时影响因子@(药理学与药学)学科排名<br>        http://impactfactor.cn/2024/iir/?ISSN=0362A5664<br><br>        SCIE(SCI)期刊CLINICAL NEUROPHARMACOLOGY(20 21 REV HIST)五年累积影响因子<br>        http://impactfactor.cn/2024/5y/?ISSN=0362-5664<br><br>        SCIE(SCI)期刊CLINICAL NEUROPHARMACOLOGY(CLIN NEUROPHARMACOL)五年累积影响因子@(药理学与药学)学科排名<br>        http://impactfactor.cn/2024/5yr/?ISSN=0362A5664<br><br>       

关心 发表于 2025-3-22 00:04:27

http://reply.papertrans.cn/1/57/5680/5680-2.png

潜伏期 发表于 2025-3-22 01:39:39

Submitted on: 11 July 2012.
Revised on: 13 September 2012.
Accepted on: 15 October 2012.

___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

AUGUR 发表于 2025-3-22 07:55:32

Submitted on: 04 September 2001.
Revised on: 24 December 2001.
Accepted on: 16 February 2002.

___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

折磨 发表于 2025-3-22 12:10:44

Submitted on: 29 July 2001.
Revised on: 20 November 2001.
Accepted on: 01 December 2001.

___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

苦恼 发表于 2025-3-22 16:47:55

http://reply.papertrans.cn/1/57/5680/5680-6.png

新奇 发表于 2025-3-22 18:02:48

http://reply.papertrans.cn/1/57/5680/5680-7.png

jeopardize 发表于 2025-3-22 21:41:56

http://reply.papertrans.cn/1/57/5680/5680-8.png

instate 发表于 2025-3-23 01:40:51

http://reply.papertrans.cn/1/57/5680/5680-9.png

carbohydrate 发表于 2025-3-23 08:42:48

http://reply.papertrans.cn/1/57/5680/5680-10.png
页: [1] 2 3 4
查看完整版本: SCIE期刊CLINICAL NEUROPHARMACOLOGY 2024/2025影响因子:0.816 (CLIN NEUROPHARMACOL) (0362-5664). (PHARMACOLOGY & PHARMACY)(药理学与药